ASX 200 up 0.55%: Cochlear jumps on FDA approval, Adbri crushed on contract loss

Adbri Ltd (ASX:ABC) and Cochlear Limited (ASX:COH) shares are making waves on the ASX 200 index on Friday. Here's why…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Friday the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a solid gain. The benchmark index is currently up 0.55% to 6,065.9 points.

Here's what has been happening on the market today:

Bank shares mixed.

The big four banks look to have run out of steam on Friday and are acting as a bit of a drag on the ASX 200. At the time of writing the National Australia Bank Ltd (ASX: NAB) share price is down around 0.6%. Whereas the Commonwealth Bank of Australia (ASX: CBA) share price is the best performer in the group with a 0.45% gain. The other two big four banks are trading slightly lower.

Adbri (Adelaide Brighton) crushed.

The Adbri Ltd (ASX: ABC) share price has crashed significantly lower on Friday after announcing the loss of a supply contract with Alcoa Australia. The current lime supply contract will not be renewed when it expires at the end of June 2021. Although this represents approximately $70 million or 4.6% of annual revenue, investors appear concerned others may follow. Alcoa revealed that it is switching to cheaper imported products. This brings to an end a supply relationship that has been ongoing for almost 50 years.

Cochlear gets FDA approval.

The Cochlear Limited (ASX: COH) share price is storming higher after receiving US FDA approval for four new hearing technology solutions products. These new products include the Nucleus Kanso 2 Sound Processor, Nucleus 7 Sound Processor for Nucleus 22 implant recipients, Custom Sound Pro fitting software, and the Nucleus SmartNav system. The four new systems will be commercially released in the United States and Western Europe in the coming months. This is subject to local approvals.

Best and worst performing ASX 200 shares.

The best performer on the ASX 200 at lunch is the Cochlear share price with a 5.5% gain. Investors appear pleased with the upcoming launch of the aforementioned innovative new products. The worst performer on the index by some distance on Friday has been the Adbri share price with a 24% decline. Investors appear concerned that the loss of the Alcoa supply contract could be the first of many.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

View of a business man's hand passing a $100 note to another with a bank in the background.
Opinions

3 ASX shares I'd buy with $10,000 today

Here's where I'd put $10,000 right now.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors enjoyed a strong hump day session today.

Read more »

Concept image of man holding up a falling arrow with a shield.
52-Week Lows

3 quality ASX shares to buy after hitting a 52-week low

3 high-quality ASX shares have been sold hard and now trade at 52-week lows.

Read more »

View from below of a banker jumping for joy in the CBD surrounded by high-rise office buildings.
Bank Shares

3 reasons to buy NAB shares in 2026

The banking giant is still a good buy in my eyes.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Share Gainers

Why Amcor, Brazilian Rare Earths, Northern Star, and Pinnacle shares are racing higher today

These shares are having a better day than most on hump day. But why?

Read more »

A young man looks like he his thinking holding his hand to his chin and gazing off to the side amid a backdrop of hand drawn lightbulbs that are lit up on a chalkboard.
Opinions

Forget Zip shares, I'd buy this fintech stock instead

I think this fintech share offers good potential this year.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why Hot Chili, Jumbo, PYC, and Xero shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »